Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Tanaka

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 28, 2011
Dysregulated oxygen metabolism of the kidney by uremic toxins: reviewChih-Kang Chiang, Tetsuhiro Tanaka, Masaomi Nangaku
The Journal of Biological Chemistry|August 22, 2012
Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the hostTetsuhiro Tanaka, Junna Yamaguchi, Kumi Shoji, et al.
Hematology. American Society of Hematology. Education Program|December 7, 2024
Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney diseaseVolker H Haase, Tetsuhiro Tanaka, Mark J Koury
Kidney International|July 10, 2014
The potential for renoprotection with incretin-based drugsTetsuhiro Tanaka, Yoshiki Higashijima, Takehiko Wada, et al.
Clinical and Experimental Pharmacology & Physiology|July 28, 2018
Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidneyYu Ishimoto, Tetsuhiro Tanaka, Yoko Yoshida, et al.
Kidney International|February 19, 2015
Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δJunna Yamaguchi, Tetsuhiro Tanaka, Nobuaki Eto, et al.
Clinical and Experimental Nephrology|March 2, 2019
Regional variance in patterns of prescriptions for chronic kidney disease in JapanReiko Inoue, Hiroshi Nishi, Tetsuhiro Tanaka, et al.
Clinical and Experimental Nephrology|June 30, 2026
Anemia prevalence and treatment patterns in chronic kidney disease: a nationwide observational study using a Japanese primary care database (2018-2023)Tetsuhiro Tanaka, Shinji Asada, Kohei Suzuki, et al.
Diabetes & Metabolism Journal|January 29, 2021
Treatment of Diabetic Kidney Disease: Current and FutureTomotaka Yamazaki, Imari Mimura, Tetsuhiro Tanaka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 25, 2013
Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremiaTetsuhiro Tanaka, Junna Yamaguchi, Yoshiki Higashijima, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 28, 2011
Dysregulated oxygen metabolism of the kidney by uremic toxins: reviewChih-Kang Chiang, Tetsuhiro Tanaka, Masaomi Nangaku
The Journal of Biological Chemistry|August 22, 2012
Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the hostTetsuhiro Tanaka, Junna Yamaguchi, Kumi Shoji, et al.
Hematology. American Society of Hematology. Education Program|December 7, 2024
Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney diseaseVolker H Haase, Tetsuhiro Tanaka, Mark J Koury
Kidney International|July 10, 2014
The potential for renoprotection with incretin-based drugsTetsuhiro Tanaka, Yoshiki Higashijima, Takehiko Wada, et al.
Clinical and Experimental Pharmacology & Physiology|July 28, 2018
Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidneyYu Ishimoto, Tetsuhiro Tanaka, Yoko Yoshida, et al.
Kidney International|February 19, 2015
Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δJunna Yamaguchi, Tetsuhiro Tanaka, Nobuaki Eto, et al.
Clinical and Experimental Nephrology|March 2, 2019
Regional variance in patterns of prescriptions for chronic kidney disease in JapanReiko Inoue, Hiroshi Nishi, Tetsuhiro Tanaka, et al.
Clinical and Experimental Nephrology|June 30, 2026
Anemia prevalence and treatment patterns in chronic kidney disease: a nationwide observational study using a Japanese primary care database (2018-2023)Tetsuhiro Tanaka, Shinji Asada, Kohei Suzuki, et al.
Diabetes & Metabolism Journal|January 29, 2021
Treatment of Diabetic Kidney Disease: Current and FutureTomotaka Yamazaki, Imari Mimura, Tetsuhiro Tanaka, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 25, 2013
Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremiaTetsuhiro Tanaka, Junna Yamaguchi, Yoshiki Higashijima, et al.
Pageof 15